Acacetin Alleviates Inflammation and Matrix Degradation in Nucleus Pulposus Cells and Ameliorates Intervertebral Disc Degeneration in vivo
Authors:
Open Access
- 1 November 2020
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 4801-4813
Abstract
Purpose: Intervertebral disc degeneration (IDD) is one of the most prevalent musculoskeletal disorders. The nucleus pulposus is the major component of the intervertebral disc, and nucleus pulposus cells (NPCs) play a significant role in the normal functioning of the intervertebral disc. Reactive oxygen species (ROS) generation, inflammation and extracellular matrix degradation in NPCs contribute to the degeneration of intervertebral discs. Acacetin is a drug that exerts antioxidant and anti-inflammatory effects on many types of cells. However, whether acacetin can relieve the degeneration of NPCs remains unknown. Methods: NPCs were extracted from rat intervertebral discs. The NPCs were treated with tert-butyl peroxide (TBHP) to simulate a high-ROS environment, and acacetin was subsequently added. The contents of ROS, inflammatory mediators (COX-2, iNOS) and extracellular matrix components (aggrecan, collagen II, MMP13, MMP9, MMP3) were measured. Components of related signaling pathways (Nrf2, MAPK) were also evaluated. To determine the effect of acacetin in vivo, we simulated disc degeneration via needle puncture. Acacetin was then applied intraperitoneally, and the degenerative status was evaluated using MRI and histopathological analysis. Results: In vitro, acacetin alleviated TBHP-induced ROS generation and upregulated the expression of antioxidant proteins, including HO-1, NQO1, and SOD. In addition, acacetin relieved the TBHP-induced generation of inflammatory mediators (COX-2, iNOS) and degradation of the extracellular matrix (aggrecan, collagen II, MMP13, MMP9, and MMP3). Acacetin exerted its effect by activating the Nrf2 pathway and inhibiting p38, JNK and ERK1/2 phosphorylation. In vivo, acacetin ameliorated puncture-induced disc degeneration in a rat tail model, which was evaluated using MRI and histopathological analysis. Conclusion: Acacetin alleviated IDD in vitro and in vivo and may have the potential to be developed as an effective treatment for IDD.Keywords
This publication has 48 references indexed in Scilit:
- AOD: the antioxidant protein databaseScientific Reports, 2017
- Development of Optimized Copolymers and Delivery Formulations to Scavenge Reactive Oxygen Species and Prevent Joint Damage from Post-Traumatic OsteoarthritisOsteoarthritis and Cartilage, 2017
- The intervertebral disc contains intrinsic circadian clocks that are regulated by age and cytokines and linked to degenerationAnnals of the Rheumatic Diseases, 2017
- Non-specific low back painThe Lancet, 2017
- ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc DegenerationOxidative Medicine and Cellular Longevity, 2017
- The complexity of the Nrf2 pathway: beyond the antioxidant responseThe Journal of Nutritional Biochemistry, 2015
- Role of cytokines in intervertebral disc degeneration: pain and disc contentNature Reviews Rheumatology, 2013
- The Effect of Injection Volume on Disc Degeneration in a Rat Tail ModelSpine, 2011
- The intervertebral disc: From pathophysiology to tissue engineeringJoint Bone Spine, 2009
- Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.Proceedings of the National Academy of Sciences, 1994